Aziyo Biologics (ELUT)
NASDAQ:ELUT
US Market
Holding ELUT?
Track your performance easily

Aziyo Biologics (ELUT) Financial Statements

54 Followers

Aziyo Biologics Financial Overview

Aziyo Biologics's market cap is currently ―. The company's EPS TTM is $-3.117; its P/E ratio is -1.24; Aziyo Biologics is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $-0.44. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 6.29M$ 6.69M$ -4.73M$ 6.13M$ 10.30M
Gross Profit$ 2.80M$ 2.84M$ 901.00K$ 2.84M$ 980.00K
EBIT$ -27.10M$ -18.12M$ -12.86M$ -7.06M$ -9.09M
EBITDA$ -26.19M$ -17.20M$ -11.91M$ -6.05M$ -8.08M
Net Income Common Stockholders$ -28.18M$ -18.00M$ -9.31M$ -9.75M$ -10.62M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 18.19M$ 12.55M$ 19.28M$ 14.52M$ 9.30M
Total Assets$ 41.90M$ 35.36M$ 43.43M$ 54.58M$ 52.33M
Total Debt$ 22.32M$ 22.01M$ 23.68M$ 25.28M$ 25.64M
Net Debt$ 4.13M$ 9.46M$ 4.40M$ 10.76M$ 16.34M
Total Liabilities$ 106.24M$ 85.66M$ 82.03M$ 84.05M$ 74.46M
Stockholders Equity$ -64.34M$ -50.30M$ -38.60M$ -29.47M$ -22.13M
Cash Flow-
Free Cash Flow$ -4.40M$ -2.62M$ -9.12M$ -5.16M$ -2.47M
Operating Cash Flow$ -4.40M$ -2.60M$ -9.10M$ -5.10M$ -2.39M
Investing Cash Flow$ 182.00K$ -15.00K$ 14.54M$ -62.00K$ -85.00K
Financing Cash Flow$ 9.79M$ -4.07M$ -695.00K$ 10.41M$ -19.00K
Currency in USD

Aziyo Biologics Earnings and Revenue History

Aziyo Biologics Debt to Assets

Aziyo Biologics Cash Flow

Aziyo Biologics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis